Anika Therapeutics, Inc. (ANIK) Free cash flow 2016–2025
Anika Therapeutics, Inc. (ANIK) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$4.4MFY2025 · since FY2016: $10.4M → $4.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.4M | +287.1% |
| FY2024 | -$2.3M | +67.7% |
| FY2023 | -$7.2M | -134.5% |
| FY2022 | -$3.1M | -194.6% |
| FY2021 | $3.3M | -71.5% |
| FY2020 | $11.4M | -66.5% |
| FY2019 | $34.2M | +12.9% |
| FY2018 | $30.3M | -4.9% |
| FY2017 | $31.8M | +205.1% |
| FY2016 | $10.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice